Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K4 | P45985 | 1/20 | 0.32 |
| ▸ | CFTR | P13569 | 1/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23905342 | 0.95 | MAP2K4 (0.34) | MAP2K4CFTRDHODHHDAC4HDAC1 | |
| SCHEMBL23905349 | 0.91 | CFTR (0.33) | MAP2K4CFTRDHODHHDAC4HDAC1 | |
| SCHEMBL23905338 | 0.91 | MAP2K4 (0.32) | MAP2K4CFTRDHODHHDAC4HDAC1 | |
| SCHEMBL23905339 | 0.91 | MAP2K4 (0.32) | MAP2K4CFTRHDAC4HDAC1HDAC6 | |
| SCHEMBL23905340 | 0.91 | CFTR (0.33) | MAP2K4CFTRDHODHHDAC4HDAC1 | |
| SCHEMBL23905330 | 0.87 | CFTR (0.31) | CFTR | |
| SCHEMBL23905462 | 0.84 | CFTR (0.36) | MAP2K4CFTRDHODHHDAC4HDAC1 | |
| SCHEMBL23904802 | 0.84 | CFTR (0.36) | MAP2K4CFTRDHODHHDAC4HDAC1 | |
| SCHEMBL23905594 | 0.82 | HDAC1 (0.31) | HDAC1HDAC6GRM2SCN9A | |
| SCHEMBL23905607 | 0.82 | KDM4E (0.33) | CFTRGRM2KCNH2SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198981-A1 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Janssen Biopharma, Inc. (US) | 2021-10-07 | — | — | WO | disclosed |